Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stuart J. Schnitt
HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
‹
1
2
Related publications
PTEN Expression as a Predictor for the Response to Trastuzumab-Based Therapy in Her-2 Overexpressing Metastatic Breast Cancer
PLoS ONE
Multidisciplinary
Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Pcn163 - Cost-Effectiveness of Add-On Pertuzumab Combined With Trastuzumab and Docetaxel Versus Placebo as Treatment of Her-2 Positive Metastatic Breast Cancer in Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Trastuzumab in Combination With Metronomic Cyclophosphamide and Methotrexate in Patients With HER-2 Positive Metastatic Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Trastuzumab-Containing Regimens for Metastatic Breast Cancer
Cochrane Database of Systematic Reviews
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis
Oncologist
Cancer Research
Medicine
Oncology
Trastuzumab in the Treatment of Metastatic Breast Cancer : Anticancer Therapy Versus Cardiotoxicity
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Cost-Utility Analysis of Adjuvant Trastuzumab Therapy for HER2-positive Early-Stage Breast Cancer in the Philippines
BMC Health Services Research
Health Policy
Addition of Everolimus and Trastuzumab to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology